The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Open accessAbstract
The altered metabolism of tumors has been considered a target for anticancer therapy. However, the relationship between distinct tumor-initiating lesions and anomalies of tumor metabolism in vivo has not been addressed. We report that MYC-induced mouse liver tumors significantly increase both glucose and glutamine catabolism, whereas MET-induced liver tumors use glucose to produce glutamine. Increased glutamine catabolism in MYC-induced liver tumors is associated with decreased levels of glutamine synthetase (Glul) and the switch from Gls2 to Gls1 glutaminase. In contrast to liver tumors, MYC-induced lung tumors display increased expression of both Glul and Gls1 and accumulate glutamine. We also show that inhibition of Gls1 kills cells that overexpress MYC and catabolize glutamine. Our results suggest that the metabolic profiles of tumors are likely to depend on both the genotype and tissue of origin and have implications regarding the design of therapies targeting tumor metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, inhibiting glutamine entry into the TCA cycle can blunt tumor progression in a MYC-driven cancer model of liver cancer (Xiang et al., 2015; Yuneva et al., 2012) and a MYC-inducible Burkitt lymphoma model (Le et al., 2012; Xiang et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2012
In the citing paper
“MYC has been found to increase mRNA and protein levels of glutamine transporters as well as expression of the enzyme glutaminase, which catalyzes the first step in glutaminolysis (Gao et al., 2009; Wise et al., 2008; Yuneva et al., 2012).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2012
In the citing paper
“Second, although different oncogenes reprogram metabolism in different ways, the tissue in which the oncogene is expressed affects the execution of metabolic reprogramming.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [5]
In the citing paper
“Transgenic MYC induces metabolic changes in both liver tumors and lung tumors but activates glutamine catabolism in lung tumors and glutamine synthesis in liver tumors.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [5]
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [179]
In the citing paper
“For example, liver tumors with aberrant overexpression of MYC display enhanced glutamine oxidation and sensitivity to therapies that target glutamine catabolism relative to liver tumors driven by overexpression of MET (196).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [196]
In the citing paper
“furthermore, a similar accumulation of glucose-derived glutamine within the tumor tissue was observed in a mouse model of c-Met-driven liver cancer (Yuneva et al., 2012).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Yuneva et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,346
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,456
Flagged first, then by citations
2 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 638
Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
van Gisbergen, M. W., Zwilling, E., & Dubois, L. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653621 · Cited by 20
Characterization of metabolic landscape in hepatocellular carcinoma
Wu, J., Xue, R., Jiang, R., & Meng, Q. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i9.1144 · Cited by 20
Falco, P. D., Lazzarino, G., Felice, F., Desideri, E., Castelli, S., Salvatori, I., Ciccarone, F., & Ciriolo, M. R. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102585 · Cited by 20
Ketogenic diet as a treatment and prevention strategy for cancer: A therapeutic alternative
Neha, N., & Chaudhary, R. (2024) · Nutrition · doi:10.1016/j.nut.2024.112427 · Cited by 20
Expanding the concepts and tools of metabolic engineering to elucidate cancer metabolism
Keibler, M. A., Fendt, S., & Stephanopoulos, G. N. (2012) · Biotechnology Progress · doi:10.1002/btpr.1629 · Cited by 23
Cooperation Between the NRF2 Pathway and Oncogenic β‐catenin During HCC Tumorigenesis
Savall, M., Senni, N., Lagoutte, I., Sohier, P., Dentin, R., Romagnolo, B., Perret, C., & Bossard, P. (2021) · Hepatology Communications · doi:10.1002/hep4.1746 · Cited by 20
Rojas, Á., García-Lozano, M. D. R., Gil‐Gómez, A., Romero‐Gómez, M., & Ampuero, J. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00247 · Cited by 21
Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
Perez, L. M., Venugopal, S. V., Martin, A. S., Freedland, S. J., Vizio, D. D., & Freeman, M. R. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.001 · Cited by 19
Two Faces of Glutaminase GLS2 in Carcinogenesis
Buczkowska, J., & Szeliga, M. (2023) · Cancers · doi:10.3390/cancers15235566 · Cited by 21
Brindle, N. R., Joyce, J. A., Rostker, F., Lawlor, E. R., Swigart, L. B., Evan, G. I., Hanahan, D., & Shchors, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120348 · Cited by 20
Liu, X., Wang, L., Jiang, W., Lu, W., Yang, J., & Yang, W. (2018) · Journal of Cancer · doi:10.7150/jca.24331 · Cited by 19
Metabolic drug survey highlights cancer cell dependencies and vulnerabilities
Pemovska, T., Bigenzahn, J. W., Srndic, I., Lercher, A., Bergthaler, A., César‐Razquin, A., Kartnig, F., Kornauth, C., Valent, P., Staber, P. B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27329-x · Cited by 19
In vivo analysis of lung cancer metabolism: nothing like the real thing
Hensley, C. T., & DeBerardinis, R. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79188 · Cited by 19
Targeting Therapy Resistance: When Glutamine Catabolism Becomes Essential
Lukey, M. J., Katt, W. P., & Cerione, R. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.009 · Cited by 19
Lee, S. M., Lee, G., & Kim, H. U. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.06.027 · Cited by 18
Adhikary, G., Shrestha, S., Naselsky, W., Newland, J. J., Chen, X., Xu, W., Emadi, A., Friedberg, J. S., & Eckert, R. L. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23497 · Cited by 18
Self-citationGLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progresses of gastric cancer
Jiang, Q., Li, Y., Cai, S., Shi, X., Yang, Y., Xing, Z., He, Z., Wang, S.-T., Su, Y., Chen, M., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.008 · Cited by 18
Balcells, C. D., Foguet, C., Tarragó‐Celada, J., de Atauri, P., Marín, S., & Cascante, M. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.12.025 · Cited by 19
Nie, S., Zhao, Y., Qiu, X., Wang, W., Yao, Y., Yi, M., & Wang, D. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/3817879 · Cited by 18
Xiao, D., He, J., Guo, Z., He, H., Yang, S., Huang, L., Pan, H., & He, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.571384 · Cited by 18
AbuSalim, J. E., Yamamoto, K., Miura, N., Blackman, B. N., Brender, J., Mushti, C., Seki, T., Camphausen, K. A., Swenson, R. E., Krishna, M. C., et al. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00561 · Cited by 18
Challenges in targeting cancer metabolism for cancer therapy
Yamaguchi, R., & Perkins, G. A. (2012) · EMBO Reports · doi:10.1038/embor.2012.176 · Cited by 18
Shi, X., Zhang, X., Yi, C., Liu, Y., & He, Q. (2015) · Molecular Imaging · doi:10.2310/7290.2014.00048 · Cited by 18
Liu, X., Song, X., Zhang, J., Xu, Z., Che, L., Qiao, Y., Pedraza, Y. O., Cigliano, A., Pascale, R. M., Calvisi, D. F., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1777 · Cited by 18
Self-citationCancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer
Cortellino, S., D’Angelo, M., Quintiliani, M., & Giordano, A. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31417 · Cited by 18
Glutamine metabolism and radiosensitivity: Beyond the Warburg effect
Alden, R. S., Kamran, M. Z., Bashjawish, B., & Simone, B. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1070514 · Cited by 18
Fidelito, G., Souza, D. P. D., Niranjan, B., Nardo, W. D., Keerthikumar, S., Brown, K., Taylor, R. A., & Watt, M. J. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0796 · Cited by 16
Liu, D., Wang, Y., Li, X., Wang, Y., Zhang, Z., Wang, Z., & Zhang, X. (2023) · Amino Acids · doi:10.1007/s00726-023-03316-y · Cited by 17
Fanconi Anemia complementation group C protein in metabolic disorders
Nepal, M. K., Ma, C., Xie, G., Jia, W. P., & Fei, P. (2018) · Aging · doi:10.18632/aging.101487 · Cited by 16
Wang, J., Yang, K., Cao, J., & Li, L. (2021) · Bioengineered · doi:10.1080/21655979.2021.2000731 · Cited by 15
Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies
Zuo, F., Yu, J., & He, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.931393 · Cited by 16
Clemente, V., Hoshino, A., Shetty, M., Nelson, A., Erickson, B. K., Baker, R., Rubin, N., Khalifa, M. A., Weroha, S. J., Lou, E., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0122 · Cited by 16
Song, X.-Q., Yu, T., Ou-Yang, Y., Ding, J.-H., Jiang, Y., Shao, Z., & Xiao, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-56458-w · Cited by 15
The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma
Guan, R., Hong, W., Huang, J., Peng, T., Zhao, Z., Lin, Y., Yu, M., & Jian, Z. (2020) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-20-186 · Cited by 15
Metabolic Vulnerabilities in Multiple Myeloma
Lim, J. S. L., Chong, P. S. Y., & Chng, W. J. (2022) · Cancers · doi:10.3390/cancers14081905 · Cited by 15
Claiborne, M. D., & Leone, R. D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1011191 · Cited by 16
Why some tumours trigger neovascularisation and others don’t: the story thus far
Adighibe, O., Leek, R., Fernández‐Mercado, M., Hu, J., Snell, C. E., Gatter, K. C., Harris, A. L., & Pezzella, F. (2016) · 癌症：英文版 · doi:10.1186/s40880-016-0082-6 · Cited by 15
Approaches and techniques to characterize cancer metabolism in vitro and in vivo
Zaimenko, I., Lisec, J., Stein, U., & Brenner, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.08.004 · Cited by 17
Preclinical study of an 18F-labeled glutamine derivative for cancer imaging
Li, C., Liu, H., Duan, D., Zhou, Z., & Liu, Z. (2018) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2018.06.007 · Cited by 15
Branched chain amino acid metabolism and cancer: the importance of keeping things in context
Selwan, E. M., & Edinger, A. L. (2017) · Translational Cancer Research · doi:10.21037/tcr.2017.05.05 · Cited by 14
Vo, V. T. A., Choi, J.-W., Phan, A. N. H., Hua, T. N. M., KIM, M.-K., Kang, B. H., Jung, S., Yong, S., & Jeong, Y. (2018) · Anticancer Research · doi:10.21873/anticanres.12460 · Cited by 14
A glance at the actual role of glutamine metabolism in thyroid tumorigenesis
Abooshahab, R., Hooshmand, K., Razavi, F., Dass, C. R., & Hedayati, M. (2021) · EXCLI journal · doi:10.17179/excli2021-3826 · Cited by 14
Kr-POK (ZBTB7c) regulates cancer cell proliferation through glutamine metabolism
Hur, M., Yoon, J.-H., Kim, M., Ko, H., & Jeon, B. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.05.005 · Cited by 14
Chhichholiya, Y., Singh, H. V., Vashistha, R., Singh, S., & Munshi, A. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104250 · Cited by 14
Gao, Y., Gong, Y., Lu, J., Hao, H., & Shi, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1377722 · Cited by 13
Breast cancers as ecosystems: a metabolic perspective
Martino, F., Lupi, M., Giraudo, E., & Lanzetti, L. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04902-9 · Cited by 14
Gaglio, D., Valtorta, S., Ripamonti, M., Bonanomi, M., Damiani, C., Todde, S., Negri, A. S., Sanvito, F., Mastroianni, F., Campli, A. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10470 · Cited by 15
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes
Kowalik, M. A., Taguchi, K., Serra, M., Caddeo, A. M., Puliga, E., Bacci, M., Koshiba, S., Inoue, J., Hishinuma, E., Morandi, A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000568 · Cited by 12
Niepmann, M. (2024) · Cancers · doi:10.3390/cancers16132290 · Cited by 12
Probing Cancer Cell Metabolism Using NMR Spectroscopy
Hollinshead, K. E. R., Williams, D. S., Tennant, D. A., & Ludwig, C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-26666-4_6 · Cited by 12
Long, Y., Qiu, J., Zhang, B., He, P., Shi, X., He, Q., Chen, Z., Shen, W., Li, Z., & Zhang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671902 · Cited by 12
Metabolic Alterations in Preneoplastic Development Revealed by Untargeted Metabolomic Analysis
Myllymäki, H., Johansson, J. A., Porro, E. G., Elliot, A. M., Moses, T., & Feng, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.684036 · Cited by 12
Akar, S., Dönmez‐Altuntaş, H., & Hamurcu, Z. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07536-5 · Cited by 12
Identification of Some Glutamic Acid Derivatives with Biological Potential by Computational Methods
Moldovan, O.-L., Sandulea, A., Lungu, I.-A., Gâz, A. Ş., & Rusu, A. (2023) · Molecules · doi:10.3390/molecules28104123 · Cited by 12
Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
D’Avola, A., Kľučková, K., Finch, A. J., & Riches, J. C. (2023) · OncoTargets and Therapy · doi:10.2147/ott.s366627 · Cited by 13
Shao, C., Lu, W., Wan, N., Wu, M., Bao, Q., Tian, Y., Lu, G., Wang, N., Hao, H., & Ye, H. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00138 · Cited by 12
Guo, W., Wang, X., Li, Y., & Bai, O. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103071 · Cited by 13
Yi, Z., Kou, J., Li, W., Wang, Y., Su, X., & Zhang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1595176 · Cited by 15
Bian, Y., Shan, G., Bi, G., Xu, Z., Liang, J., Yan, Y., Guo, W., Sui, Q., Yi, Y., Shi, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65441-4 · Cited by 11
Tao, T., Feng, X., Yang, Y., Liu, B., Liang, J., Chen, Z., Wang, S., Zhao, J., Yang, X., Huo, L., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01905-z · Cited by 11
Glutamine Addiction of Cancer Cells
Desideri, E., & Ciriolo, M. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1932-1_8 · Cited by 11
Dou, Q., Grant, A. K., de Souza, P. C., Moussa, M., Nasser, I. A., Ahmed, M., & Tsai, L. L. (2024) · Radiology Imaging Cancer · doi:10.1148/rycan.230056 · Cited by 11
METabolic Adaptations in the Tumor MYCroenvironment
Davidson, S. M., & Heiden, M. G. V. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.005 · Cited by 11
Tipanee, J., Matteo, M. D., Tulalamba, W., Samara-Kuko, E., Keirsse, J., Ginderachter, J. A. V., Chuah, M., & VandenDriessche, T. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.015 · Cited by 11
Canceromics Studies Unravel Tumor’s Glutamine Addiction After Metabolic Reprogramming
Márquez, J., Matés, J. M., Alonso, F. J., Martín‐Rufián, M., Lobo, C., & Campos-Sandoval, J. A. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_12 · Cited by 11
Self-citationGlutamine synthetase and hepatocellular carcinoma
Jiang, J., Hu, Y., Fang, D., & Luo, J. (2023) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2023.102248 · Cited by 10
The Role and Treatment Strategies of Ammonia-Related Metabolism in Tumor Microenvironment
Ye, Q., Li, D., Zou, Y., & Yuan, Y. (2024) · Current Gene Therapy · doi:10.2174/0115665232301222240603100840 · Cited by 10
Kinslow, C. J., ll, M. B., Cai, Y., Yan, J., Lorkiewicz, P., Al‐Attar, A., Tan, J., Higashi, R. M., Lane, A. N., & Fan, T. W. ‐. (2024) · Metabolomics · doi:10.1007/s11306-024-02126-x · Cited by 10
Self-citationLuo, R., Zhao, H., Deng, S., Wu, J., Wang, H., Guo, X., Han, C., Ren, W., Han, Y., Zhou, J., et al. (2024) · Molecules · doi:10.3390/molecules29184375 · Cited by 10
Inferring Gene Regulatory Networks of Metabolic Enzymes Using Gradient Boosted Trees
Zhang, Y., Zhang, X., Lane, A. N., Fan, T. W. ‐., & Liu, J. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2019.2931997 · Cited by 11
Self-citationNetwork, nodes and nexus: systems approach to multitarget therapeutics
Murthy, D., Attri, K. S., & Gokhale, R. S. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.02.009 · Cited by 10
Cancer stem cells amino acid metabolism: Roles, mechanisms, and intervention strategies
Gong, Y., Wang, X., Chen, W., Tsai, H., & Liu, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111903 · Cited by 9
Generation of c-Myc transgenic pigs for autosomal dominant polycystic kidney disease
Ye, J., He, J. H., Li, Q., Feng, Y., Bai, X., Chen, X., Zhao, Y., Hu, X., Yu, Z., & Li, N. (2013) · Transgenic Research · doi:10.1007/s11248-013-9707-6 · Cited by 9
Self-citationMancini, M., Thomas, Q. D., Bourdel, S., Papon, L., Bousquet, E., Jalta, P., Monica, S. L., Travert, C., Alfieri, R. R., Quantin, X., et al. (2021) · Cancers · doi:10.3390/cancers13143441 · Cited by 9
Wilkie, M. D., Anaam, E. A., Lau, A., Rubbi, C. P., Vlatković, N., Jones, T. M., & Boyd, M. T. (2021) · Cancers · doi:10.3390/cancers13194836 · Cited by 9
Targeting Metabolic Pathways in Kidney Cancer
Hoerner, C. R., Miao, S. Y., Hsieh, J. J.-D., & Fan, A. C. (2020) · The Cancer Journal · doi:10.1097/ppo.0000000000000472 · Cited by 9
Shirmanova, M. V., Sinyushkina, S. D., & Komarova, A. D. (2023) · Molecular Biology · doi:10.31857/s0026898423060186 · Cited by 8
Hu, H., Ning, S., Liu, F., Zhang, Z., Zeng, W., Liu, Y., Liao, Z., Zhang, H., & Zhang, Z. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c21998 · Cited by 8
The metabolic basis of regulated cell death
Liu, J., Wang, J., Kang, R., Kroemer, G., & Tang, D. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.06.001 · Cited by 9
Song, K., Lee, H. S., Jia, L., Chelakkot, C., Rajasekaran, N., & Shin, Y. K. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.0067 · Cited by 8
Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma
Farah, C., Mignion, L., & Jordan, B. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031725 · Cited by 8
The Metabolism of Renal Cell Carcinomas and Liver Cancer
Nguyen, T. A., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_8 · Cited by 8
Glutamine metabolism in the proliferation of GS-expression pituitary tumor cells
Hu, J., Chen, Q., Ding, X., Zheng, X., Tang, X., Li, S., & Yang, H. (2020) · Endocrine Connections · doi:10.1530/ec-19-0515 · Cited by 8
Basheer, H. A., Elsalem, L., Salem, A., Tailor, A., Hunter, K. D., & Afarinkia, K. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009622666211224111425 · Cited by 8
Farah, C., Neveu, M.-A. C., Yelek, C., Bouzin, C., Gallez, B., Baurain, J., Mignion, L., & Jordan, B. F. (2022) · Biomedicines · doi:10.3390/biomedicines10030717 · Cited by 8
Chen, Z., Long, Y., Zhang, Y., Zhang, B., He, Q., & Zhang, X. (2022) · European Radiology · doi:10.1007/s00330-022-09186-4 · Cited by 9
Shen, X., Dong, P., Kong, J., Sun, N., Wang, F., Sang, L., Xu, Y., Zhang, M., Chen, X., Guo, R., et al. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3869 · Cited by 9
Self-citationMetabolic Fluxes in Cancer Metabolism
Günther, U. L., Chong, M., Volpari, T., Koczula, K. M., Atkins, K. L., Bunce, C. M., & Khanim, F. L. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_14 · Cited by 8
Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity
Cuyàs, E., Verdura, S., Fernández‐Arroyo, S., Bosch‐Barrera, J., Martı́n-Castillo, B., Joven, J., & Menéndez, J. A. (2017) · Oncotarget · doi:10.18632/oncotarget.21834 · Cited by 8
Targeting cancer metabolism through synthetic lethality-based combinatorial treatment strategies
Bajpai, R., & Shanmugam, M. (2018) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000467 · Cited by 8
Même l’effet Warburg est oxydable: Coopération métabolique et développement tumoral
Cordier–Bussat, M., Thibert, C., Sujobert, P., Genestier, L., Fontaine, E. M., & Billaud, M. (2018) · HAL · doi:10.1051/medsci/20183408017 · Cited by 7
Challenges of Spatially Resolved Metabolism in Cancer Research
Lane, A. N., Higashi, R. M., & Fan, T. W. ‐. (2024) · Metabolites · doi:10.3390/metabo14070383 · Cited by 8
Self-citationDecoding the NRF2–NOTCH Crosstalk in Lung Cancer—An Update
Sparaneo, A., Torrisi, F., D’Angeli, F., Giurdanella, G., Bravaccini, S., Muscarella, L. A., & Fabrizio, F. P. (2025) · Antioxidants · doi:10.3390/antiox14060657 · Cited by 11
Impaired nitrogenous waste clearance promotes hepatocellular carcinoma
Han, X., Shen, J., Yan, J., Tacke, R., Dai, W., Mao, Q., Queen, H., Liu, S., Islam, A., Liu, T., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec0766 · Cited by 7
Self-citationFan, T. W. ‐., Winnike, J. H., Al‐Attar, A., Belshoff, A. C., Lorkiewicz, P. K., Tan, J. L., Wu, M., Higashi, R. M., & Lane, A. N. (2023) · Metabolites · doi:10.3390/metabo13070774 · Cited by 7
Self-citationZhang, L., Su, K., Liu, Q., Li, B., Wang, Y., Cheng, C., Li, Y., Xu, C., Chen, J., Wu, H., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11601-y · Cited by 7
Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma
Serra, M., Columbano, A., Perra, A., & Kowalik, M. A. (2020) · Cancers · doi:10.3390/cancers12113318 · Cited by 7
A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil
Zhang, J., Zhang, S., Shi, Q., Allen, T. D., You, F., & Yang, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248355 · Cited by 7
Self-citationBurska, A. N., Ilyassova, B., Dildabek, A., Khamijan, M., Бегимбетова, Д., Molnár, F., & Sarbassov, D. D. (2022) · Cells · doi:10.3390/cells11213454 · Cited by 7
Regional tumour glutamine supply affects chromatin and cell identity
Højfeldt, J. W., & Helin, K. (2016) · Nature Cell Biology · doi:10.1038/ncb3414 · Cited by 7
Metadata
- Authors
- Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., Chen, X., & Bishop, J. M.
- Affiliations
- University of California, San Francisco (US)
- University of Louisville (US)
- Johns Hopkins University (US)
- Universidad de Málaga (ES)
- Corresponding author
- Yuneva, Mariia O.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 15
- Issue
- 2
- Pages
- 157-170
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3282107
- OpenAlex
- W2036659083
- Cited by
- 639
- References
- 64
- Citations by year
- 2026: 17 · 2025: 37 · 2024: 35 · 2023: 41 · 2022: 53 · 2021: 66 · 2020: 43 · 2019: 59 · 2018: 45 · 2017: 63 · 2016: 47 · 2015: 39 · 2014: 42 · 2013: 34 · 2012: 16
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R35CA044338, R01CA118434)
- National Institute of Neurological Disorders and Stroke (R21NS074151)
- National Center for Research Resources (P20RR018733)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cancer metabolism, c-Myc, MET, glutamine catabolism, glutamine synthetase, glutaminase, GLS1, GLS2, liver tumors, lung cancer, genetic lesions, glutamine accumulation
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Citric Acid Cycle, Glucokinase, Glucose, Glutamine, Humans, Immunohistochemistry, Isotope Labeling, Liver Neoplasms, Experimental, Lung Neoplasms, Immunoblotting, Blotting, Western, Proto-Oncogene Proteins c-myc, DNA Primers, Lactic Acid, Proto-Oncogene Proteins c-met, Nuclear Magnetic Resonance, Biomolecular, RNA Interference, Cell Line, Tumor, Mice, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
